Inventor · disambiguated record
Sefik Alkan
Also filed as: ALKAN SEFIK · ALKAN SEFIK S
10 granted patents·8 pending applications·251 citations·filing 1985–2021
90Inventor score
Files withALBA THERAPEUTICS CORP5CIBA GEIGY CORP53M INNOVATIVE PROPERTIES CO2UCP GEN PHARMA AG2ALKAN SEFIK1
Top patents by PatentIndex Score
18 records- 0193US4885166AHybrid interferonsCIBA GEIGY CORP·Filed 1986·Granted Dec 5, 1989·110 cites·8 claims
- 0290US4780401ANovel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applicationsCIBA GEIGY CORP·Filed 1985·Granted Oct 25, 1988·71 cites·13 claims
- 0384US11149063B2Peptide inhibitors of tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2019·Granted Oct 19, 2021·2 cites·9 claims
- 0481US9006194B2Compositions and methods for diminishing viral infection and inflammation associated with viral infectionKATSIKIS PETER D·Filed 2009·Granted Apr 14, 2015·13 cites·6 claims
- 0581US5071761AHybrid interferonsCIBA GEIGY CORP·Filed 1989·Granted Dec 10, 1991·30 cites·11 claims
- 0679US8957032B2Inhibition of gliadin peptidesALKAN SEFIK·Filed 2009·Granted Feb 17, 2015·6 cites·5 claims
- 0778US10526372B2Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2018·Granted Jan 7, 2020·2 cites·14 claims
- 0873US2022009965A1Peptide inhibitors of tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 0954US2017096451A1Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 1052US2008132481A1Interleukin-4 gene expression inhibitorsAVENTIS PHARMA INC·Filed 2007·Application pending·0 cites
- 1150US2015203537A1Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
- 1244US2005226878A1Therapeutic combinations and methods including IRM compounds3M INNOVATIVE PROPERTIES CO·Filed 2005·Application pending·0 cites
- 1343US2006142202A1Compositions and methods for targeted delivery of immune response modifiers3M INNOVATIVE PROPERTIES CO·Filed 2006·Application pending·0 cites
- 1440US6342373B1Process for preparing recombinant eglin, protease inhibitorUCP GEN PHARMA AG·Filed 1991·Granted Jan 29, 2002·9 cites·3 claims
- 1537US5242819ADNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinaseCIBA GEIGY CORP·Filed 1991·Granted Sep 7, 1993·5 cites·7 claims
- 1637US2012027720A1Peptide conjugatesTAMIZ AMIR·Filed 2011·Application pending·0 cites
- 1736US2002142414A1Process for the preparation of protease inhibitorsUCP GEN PHARMA AG·Filed 2001·Application pending·0 cites
- 1832US5580559AHybrid plasminogen activatorCIBA GEIGY CORP·Filed 1994·Granted Dec 3, 1996·3 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Sefik Alkan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →